Vaishali Pharma Balance Sheet Annual

BSE: - | NSE: VAISHALI | ISIN: INE972X01022 | Sector: Biotechnology & Drugs

7.78 -0.13 (-1.64%)Updated : 15 Oct 2026

Research on

Interim Data

Annual Data

Fiscal Period	2026	2025	2024	2023
Period End Date	Mar 26	Mar 25	Mar 24	Mar 23
Total Liabilities Shareholders' Equity	123.26	109.84	79.96	78.90
Accumulated Depreciation Total	-2.47	-2.01	-1.66	-
Other Liabilities Total	0.29	0.26	0.20	0.19
Accrued Expenses	0.24	0.27	0.31	-
Long Term Debt	5.69	4.20	3.60	5.23
Common Stock Total	26.09	26.09	10.72	10.55
Other Equity Total	0.22	0.19	0.18	-
Other Current Assets Total	1.03	0.58	0.55	3.59
Prepaid Expenses	0.00	0.06	0.04	-
Total Assets	123.26	109.84	79.96	78.90
Current Portof LT Debt/ Capital Leases	0.89	3.40	2.04	1.29
Additional Paid- In Capital	22.91	22.91	17.03	-
Cash	1.11	1.71	1.46	-
Total Equity	68.99	64.92	42.84	40.53
Long Term Investments	6.75	1.75	1.75	2.71
Retained Earnings( Accumulated Deficit)	19.76	15.73	14.91	29.99
Total Common Shares Outstanding	13.05	13.05	10.72	10.55
Property/ Plant/ Equipment Total- Gross	3.63	3.17	3.11	-
Tangible Book Valueper Share Common Eq	5.23	4.91	3.92	3.76
Total Liabilities	54.27	44.93	37.12	38.37
Total Debt	18.89	12.32	13.49	14.74
Short Term Investments	32.09	28.28	12.01	11.44
Cashand Short Term Investments	33.20	29.99	13.47	12.42
Total Receivables Net	51.89	47.66	50.11	53.61
Notes Payable/ Short Term Debt	12.31	4.30	7.62	7.34
Accounts Receivable- Trade Net	50.77	46.72	49.43	53.61
Property/ Plant/ Equipment Total- Net	1.15	1.16	1.46	1.80
Total Current Liabilities	48.30	40.05	33.08	32.07
Total Inventory	26.85	26.20	10.35	3.05
Accounts Payable	21.18	27.14	19.39	18.00
Other Currentliabilities Total	13.69	4.94	3.72	5.44
Total Long Term Debt	5.69	4.62	3.83	6.11
Intangibles Net	0.79	0.92	0.80	0.86
Other Long Term Assets Total	0.87	0.80	0.71	0.86
Note Receivable- Long Term	0.73	0.73	0.72	-
period Length	0.00	0.00	0.00	0.00
Total Current Assets	112.96	104.48	74.52	72.67
Capital Lease Obligations	0.00	0.42	0.24	0.88
Cash Equivalents	-	-	-	0.98